Notes - Segment Information, Etc.

KAKEN PHARMACEUTIAL CO., LTD. - Filing #7247222

Concept 2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
Notes - Segment information, etc.
Segment information
Disclosure of sales, profit (loss), asset, liability, and other items for each reportable segment
Sales
Revenues from external customers
2,481,000,000 JPY
94,035,000,000 JPY
94,035,000,000 JPY
91,553,000,000 JPY
JPY
72,044,000,000 JPY
JPY
2,430,000,000 JPY
72,044,000,000 JPY
69,613,000,000 JPY
Transactions with other segments
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Other items
Depreciation
340,000,000 JPY
3,426,000,000 JPY
3,426,000,000 JPY
3,086,000,000 JPY
JPY
3,174,000,000 JPY
JPY
321,000,000 JPY
3,174,000,000 JPY
2,853,000,000 JPY
Increase in property, plant and equipment and intangible assets
56,000,000 JPY
17,270,000,000 JPY
17,270,000,000 JPY
17,214,000,000 JPY
JPY
7,946,000,000 JPY
JPY
8,000,000 JPY
7,946,000,000 JPY
7,937,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.